U.S. market Closed. Opens in 1 day 6 hours

MAIA | MAIA Biotechnology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/A
Operating Expenses20.18M15.86M7.74M6.98M6.92M
Selling, General & Admin9.07M6.14M4.29M5.56M5.01M
Research & Development11.11M8.62M3.45M1.41M1.91M
Other Operating ExpensesN/A1.10MN/AN/AN/A
Operating Income-20.18M-16.18M-7.79M-6.98M-6.92M
Other Expenses / Income409.48K406.92K-4.79M16.35K246.00
Before Tax Income-19.77M-15.77M-12.58M-6.96M-6.92M
Income Tax ExpensesN/A36.69K707.53K-291.04K-435.25K
Net Income-19.77M-15.81M-13.29M-6.67M-6.49M
Interest ExpensesN/A6.97K827.54K32.23KN/A
Basic Shares Outstanding13.26M9.28M10.64M10.64M10.64M
Diluted Shares Outstanding13.26M9.28M10.64M10.64M10.64M
EBITDA-20.18M-16.18MN/AN/A242.00
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-19.77M-15.76M-11.75M-6.93M-6.93M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙